期刊文献+

组织蛋白酶L在心血管病中的研究进展 被引量:4

Advances of Cathepsin L in Cardiovascular Diseases
原文传递
导出
摘要 组织蛋白酶L(Cathepsin L,CatL)属于木瓜蛋白酶,CatL由一个信号肽、一个前肽和一个酶的催化反应区组成。在一系列信号肽的作用下,CatL定位到高尔基体,并在此被高甘露糖碳水化合物转化化为CatL酶原,与两个6-磷酸甘露糖受体中的一个结合形成复合物,然后被转运至前溶酶体。此处的酸性环境可使酶和受体复合物分离,并促进酶的激活形成成熟的CatL,经过一系列反应形成小分子片段,才能完全活化,经过一系的反应后,被释放到胞质或组织间隙,可降解细胞成分或细胞间质基质成分,参与肿瘤的浸润与转移、关节炎、骨质疏松等慢性炎症性疾病的发生发展过程。近年来的研究发现,CatL在心血管疾病组织中有表达,提示组织蛋白酶L在心血管疾病中也起着非常重要的作用。 Cathepsin L(CatL) belonged to family of papains, it was composed of signal peptide, a former peptide and an enzyme catalysis area. Under the action of a series of signal peptide, CatL was oriented to the golgiosome apparatus, and CatL enzymes was formed in this high mannose carbohydrates glycosyl, and integrated by one of two phosphate mannose receptor to be the complex and then was transported to the former lysosome where the acidic environment can make the complex of enzymes and re- ceptors separate to be mature CarL,after a series of the small molecules formed,when it can be activate completely and released into the cytoplasm or the interstitial space, CatL can degrade cellular components of interstitial matrix components or involved in the development process of tumor invasion and metastasis, arthritis, osteoporosis, chronic inflammatory diseases. It had been found in recent studies that cathepsin L was expressed in the tissue of cardiovascular disease, which suggested that cathepsin L also played a very important role in cardiovascular disease.
出处 《中华全科医学》 2011年第2期269-270,共2页 Chinese Journal of General Practice
关键词 组织蛋白酶L 动脉粥样硬化 扩张型心肌病 冠心病 心肌炎 Cathepsin L Atherosclerosis Dilated cardiomyopathy Coronary heart disease Myocarditis
  • 相关文献

参考文献8

二级参考文献48

  • 1贺茂林,陈安民.反义表达人组织蛋白酶L对骨肉瘤细胞侵袭特性的影响[J].中国矫形外科杂志,2005,13(1):43-46. 被引量:3
  • 2马宾,牛小麟,王明霞,任付先.参麦注射液对扩张型心肌病患者免疫功能的影响[J].中国中西医结合杂志,2005,25(4):320-323. 被引量:20
  • 3吕浩然,刘尚礼,丁悦,黄东生,马若凡,胡宝山,叶伟.动物模型椎间盘退变全程基因变化的对比[J].中国矫形外科杂志,2005,13(11):846-849. 被引量:7
  • 4[1]Rose A M, Sandra F W, David J E, et al. Susceptibility of the cartilage collagens types Ⅱ , Ⅺ and Ⅺ to degradation by the cysteine proteinase, cathepsins B and L [J]. FEBS,1990;269:189
  • 5[2]Kahori T, Hisao K, Hiroshi K, et al. The mechanisms and regulation of procathepsin L secretion from osteoclasts in bone resorption [J]. FEBS,1994;342:308
  • 6[3]Kremer M, Judd B R, Auszmann J, et al. Estrogen modulation of osteoclast lysosomal enzyme secretion [J]. J Cell Biochem, 1995;57:271
  • 7[4]Hisao K, Takeshi N, Kahori T, et al. Participation of cathepsin L on bone resorption [J]. FEBS ,1993;321:247
  • 8全国心肌炎 心肌病专题研讨会组委会.全国心肌炎心肌病专题研讨会纪要[J].临床心血管病杂志,1995,11:324-326.
  • 9Cullen P, Baetta R, Bellosta S, et al. Rupture of the atherosclerotic plaque: does a good animal model exist?Arterioscler Thromb Vasc Biol, 2003,23:535-542.
  • 10Huang X, Vaag A, Carlsson E, et al. Impaired cathepsin L gene expression in skeletal muscle is associated with type 2 diabetes. Diabetes,2003,52:2411-2418.

共引文献32

同被引文献46

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部